Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-04-28 4:58 pm Purchase | 2022-04-19 | 13D | Inozyme Pharma, Inc. INZY | Nan Fung Group Holdings Limited | 2,661,154 6.600% | 1,070,000 (+67.25%) | Filing History |
| 2022-04-28 4:50 pm Purchase | 2022-04-19 | 13D | Inozyme Pharma, Inc. INZY | Longitude Capital Partners III LLC | 4,174,379 10.400% | 1,355,000 (+48.06%) | Filing History |
| 2022-04-25 3:05 pm Purchase | 2022-04-14 | 13G | Inozyme Pharma, Inc. INZY | Rock Springs Capital Management LP | 2,452,637 6.120% | 2,452,637 (New Position) | Filing History |
| 2022-04-18 4:15 pm Purchase | 2022-04-14 | 13G | Inozyme Pharma, Inc. INZY | Deep Track Capital, LP | 3,250,000 8.110% | 3,250,000 (New Position) | Filing History |
| 2022-02-14 09:26 am Unchanged | 2021-12-31 | 13G | Inozyme Pharma, Inc. INZY | Nan Fung Group Holdings Limited | 1,591,154 6.700% | 0 (Unchanged) | Filing History |
| 2022-02-11 4:37 pm Purchase | 2021-12-31 | 13G | Inozyme Pharma, Inc. INZY | Deerfield Mgmt, L.P. | 2,344,786 9.910% | 1,194,487 (+103.84%) | Filing History |
| 2022-02-10 09:22 am Purchase | 2021-12-31 | 13G | Inozyme Pharma, Inc. INZY | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,599,028 6.760% | 310,356 (+24.08%) | Filing History |
| 2022-02-07 1:58 pm Unchanged | 2021-12-31 | 13G | Inozyme Pharma, Inc. INZY | New Enterprise Associates 15 L.P. | 2,437,689 10.300% | 0 (Unchanged) | Filing History |
| 2021-11-15 4:35 pm Sale | 2021-11-15 | 13G | Inozyme Pharma, Inc. INZY | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -2,003,653 (Position Closed) | Filing History |
| 2021-07-30 4:31 pm Sale | 2021-07-26 | 13D | Inozyme Pharma, Inc. INZY | Novo Holdings A/S | 1,167,706 4.970% | -801,673 (-40.71%) | Filing History |
| 2021-05-10 4:05 pm Purchase | 2021-04-29 | 13G | Inozyme Pharma, Inc. INZY | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,288,672 5.490% | 1,288,672 (New Position) | Filing History |
| 2021-03-30 4:55 pm Sale | 2021-03-25 | 13D | Inozyme Pharma, Inc. INZY | Novo Holdings A/S | 1,969,379 8.400% | -225,000 (-10.25%) | Filing History |
| 2021-03-04 06:20 am Purchase | 2020-07-28 | 13D | Inozyme Pharma, Inc. INZY | Sofinnova Venture Partners X L.P. | 2,028,308 8.700% | 2,028,308 (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Inozyme Pharma, Inc. INZY | RA CAPITAL MANAGEMENT L.P. | 2,003,653 8.600% | 2,003,653 (New Position) | Filing History |
| 2021-02-12 1:30 pm Purchase | 2020-12-31 | 13G | Inozyme Pharma, Inc. INZY | New Enterprise Associates 15 L.P. | 2,437,689 10.400% | 2,437,689 (New Position) | Filing History |
| 2021-02-09 5:08 pm Unchanged | 2020-12-31 | 13G | Inozyme Pharma, Inc. INZY | Nan Fung Group Holdings Limited | 1,591,154 6.800% | 0 (Unchanged) | Filing History |
| 2021-02-01 4:31 pm Sale | 2021-01-28 | 13D | Inozyme Pharma, Inc. INZY | Novo Holdings A/S | 2,194,379 9.400% | -375,000 (-14.59%) | Filing History |